DarshanTalks Podcast

406 Avsnitt

1. Will New Tariffs Disrupt Your Next Pharma Deal?

   Publicerades: 2025-02-26
2. Protecting Patient Data in a Changing Regulatory Landscape

   Publicerades: 2025-02-25
3. Off-Label Promotion Changes in 2025

   Publicerades: 2025-02-24
4. Turning Physicians into Leaders

   Publicerades: 2025-02-21
5. Key Regulatory Agencies in Pharma M&A

   Publicerades: 2025-02-20
6. Does E6 (R3) Blur the Line Between GCP and Privacy Laws?

   Publicerades: 2025-02-19
7. RFK Jr. Confirmed as HHS Secretary: What It Means for Healthcare Policy

   Publicerades: 2025-02-18
8. America’s Research Future in Jeopardy

   Publicerades: 2025-02-15
9. Trump Administration’s NIH cuts: Will they cripple US medical research?

   Publicerades: 2025-02-14
10. DEI Under Trump: What It Means for Clinical Trials

    Publicerades: 2025-02-13
11. CAPA & RCA: A Must for Pharma M&A

    Publicerades: 2025-02-12
12. Trump Targets Indirect Costs in NIH Funding

    Publicerades: 2025-02-11
13. The USAID Halt and Its Consequences for Clinical Research

    Publicerades: 2025-02-10
14. Ebola Vaccine Trial in Record Time!

    Publicerades: 2025-02-08
15. Your Clinical Trial Site M&A Agreement is Exposing You to Risk

    Publicerades: 2025-02-07
16. What Does ICH E6 R3 Say About Returning Data to Participants?

    Publicerades: 2025-02-05
17. Navigating the Ongoing HHS Communication Freeze

    Publicerades: 2025-02-04
18. Ordinary People Are Changing Medicine

    Publicerades: 2025-02-03
19. Trump’s First 10 Days: The Impact on Clinical Trials

    Publicerades: 2025-01-31
20. Selling a Business with Issues

    Publicerades: 2025-01-31